Psychedelic psychotherapy is gaining growing attention.
Over recent decades, robust research in clinical and psychotherapeutic contexts has examined the therapeutic potential of psychedelic compounds. Today, regulatory processes are advancing across multiple countries; selected psychedelic-assisted treatments are available in many jurisdictions already today, whereas non-pharmacological modalities (e.g., immersive breathwork) are accessible everywhere.
However, psychedelic therapy is not solely pharmacological. The therapeutic context, therapist competencies, the patient-therapist relationship, and psychotherapeutic methods applied throughout preparatory, dosing, and integration sessions are central to its effectiveness.
The Importance of Professional Training
Although interest in psychedelic therapies is growing, many clinicians feel inadequately prepared to deliver these interventions safely and effectively. Clinical trials are conducted in highly controlled environments and often involve carefully selected participants. In routine practice, clinicians face greater variability in patient presentations, including complex psychiatric comorbidities and differing levels of psychosocial support. Furthermore, treatments must be individually tailored to optimize safety and efficacy, all while using available resources and accommodating local constraints.
